Top Consumer Driven Health Care Stories
Sprout investors say Valeant overcharging for female libido pill
By Cynthia KoonsSprout says Valeant, who bought the drug in 2015 for $1 billion, failed in its duties to commercialize the pill.
Consumer Driven Health Care
The latest news and trends in the consumer-driven health care space, with expert analysis from actual brokers and compliance experts